Hongping Wei Selected Research

pyrazinamide deamidase

1/2014	Rapid detection of Mycobacterium tuberculosis and pyrazinamide susceptibility related to pncA mutations in sputum specimens through an integrated gene-to-protein function approach.
1/2011	Rapid colorimetric testing for pyrazinamide susceptibility of M. tuberculosis by a PCR-based in-vitro synthesized pyrazinamidase method.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hongping Wei Research Topics

Disease

7	COVID-19 01/2022 - 01/2021
5	Infections 01/2022 - 01/2011
3	Tuberculosis (Tuberculoses) 01/2015 - 01/2011
1	Bacterial Infections (Bacterial Infection) 06/2022
1	Mycoplasma Pneumonia 01/2022
1	Burns 12/2021
1	Bacterial Pneumonia 11/2020
1	Bacteremia 01/2019
1	Sepsis (Septicemia) 12/2018
1	Esophageal Stenosis (Esophageal Stricture) 10/2018
1	Hypothyroidism 07/2016
1	Mental Disorders (Mental Disorder) 07/2016
1	Extensively Drug-Resistant Tuberculosis 01/2015
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2015
1	Human Influenza (Influenza) 01/2013
1	Fever (Fevers) 10/2012
1	Anthrax 10/2012
1	Virus Diseases (Viral Diseases) 10/2011
1	Neoplasms (Cancer) 05/2009

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2011
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2013
3	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 12/2018
2	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2022
2	VaccinesIBA 01/2022 - 10/2012
2	Peptides (Polypeptides)IBA 01/2021 - 05/2009
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2015 - 10/2012
2	pyrazinamide deamidaseIBA 01/2014 - 01/2011
1	SolutionsIBA 06/2022
1	TriterpenesIBA 01/2022
1	SimeprevirIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2022
1	Glycyrrhetinic Acid (Po 12)IBA 01/2022
1	Inactivated VaccinesIBA 01/2022
1	Dihydrotachysterol (AT 10)IBA 01/2022
1	AntigensIBA 01/2022
1	AntibodiesIBA 01/2022
1	SaponinsIBA 01/2022
1	CRISPR-Cas Systems Guide RNAIBA 12/2021
1	BuffersIBA 12/2021
1	Antimicrobial PeptidesIBA 12/2021
1	Minocycline (Cyclops)FDA LinkGeneric 12/2021
1	Synthetic Vaccines (Recombinant Vaccines)IBA 10/2021
1	SARS-CoV-2 spike proteinIBA 01/2021
1	EpitopesIBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Choline (Choline Chloride)IBA 11/2020
1	Penicillin G (Benzylpenicillin)FDA LinkGeneric 01/2019
1	Viral ProteinsIBA 01/2013
1	5' Untranslated Regions (5' UTR)IBA 01/2013
1	Phosphotransferases (Kinase)IBA 05/2009

Therapy/Procedure

3	Therapeutics 03/2021 - 10/2012
1	Phage Therapy 01/2022
1	Intraperitoneal Injections 01/2019
1	Transplantation 10/2018
1	Quantum Dots (Quantum Dot) 10/2011